Jefferson Researchers Find Immune Response and Dosing Keys to Vaccine’s Success Against Melanoma
(Published 2-12-2004) How well a patient’s immune system reacts to his own cancer cells and the schedule by which the vaccine
is given are two key factors in the success of a custom-made vaccine created from the cancer cells of patients with malignant
melanoma, the deadliest form of skin cancer and fastest growing cancer in the United States.
A Chance To Speak Up
(Published 2-13-2004) People with chronic hoarseness and breathy voices often learn to live with their impediment, accepting
it as an unfortunate characteristic that they feel can never change.